AU2007286756B2 - Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds - Google Patents

Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds Download PDF

Info

Publication number
AU2007286756B2
AU2007286756B2 AU2007286756A AU2007286756A AU2007286756B2 AU 2007286756 B2 AU2007286756 B2 AU 2007286756B2 AU 2007286756 A AU2007286756 A AU 2007286756A AU 2007286756 A AU2007286756 A AU 2007286756A AU 2007286756 B2 AU2007286756 B2 AU 2007286756B2
Authority
AU
Australia
Prior art keywords
compound
another embodiment
compound according
phenyl
replaced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007286756A
Other languages
English (en)
Other versions
AU2007286756A1 (en
Inventor
David W. Old
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of AU2007286756A1 publication Critical patent/AU2007286756A1/en
Priority to AU2009244325A priority Critical patent/AU2009244325B2/en
Application granted granted Critical
Publication of AU2007286756B2 publication Critical patent/AU2007286756B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2007286756A 2006-08-23 2007-08-21 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds Ceased AU2007286756B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2009244325A AU2009244325B2 (en) 2006-08-23 2009-05-06 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82329706P 2006-08-23 2006-08-23
US60/823,297 2006-08-23
PCT/US2007/076410 WO2008024765A2 (en) 2006-08-23 2007-08-21 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2009244325A Division AU2009244325B2 (en) 2006-08-23 2009-05-06 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds

Publications (2)

Publication Number Publication Date
AU2007286756A1 AU2007286756A1 (en) 2008-02-28
AU2007286756B2 true AU2007286756B2 (en) 2013-10-17

Family

ID=39007836

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007286756A Ceased AU2007286756B2 (en) 2006-08-23 2007-08-21 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds

Country Status (7)

Country Link
US (2) US7659295B2 (https=)
EP (1) EP2054409A2 (https=)
JP (2) JP5474548B2 (https=)
AU (1) AU2007286756B2 (https=)
BR (1) BRPI0715974A2 (https=)
CA (1) CA2661827A1 (https=)
WO (1) WO2008024765A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2010149494A (ru) 2008-05-09 2012-06-20 Аллерган, Инк. (Us) Терапевтические замещенные тиазолидиноны, оксазолидиноны и родственные соединения
US7985765B2 (en) * 2008-08-20 2011-07-26 Allergan, Inc. Therapeutic substituted pyrroles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US5902726A (en) * 1994-12-23 1999-05-11 Glaxo Wellcome Inc. Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
JP2004002206A (ja) * 2000-07-26 2004-01-08 Chugai Pharmaceut Co Ltd 光学活性なチアゾリジノン誘導体の製造方法
EP1307193A1 (en) * 2000-07-27 2003-05-07 Affymax Research Institute Agonists of follicle stimulating hormone activity
AU2003258433A1 (en) 2002-08-28 2004-03-19 Merck Frosst Canada Ltd Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma
CA2599425C (en) 2005-03-10 2013-04-30 Allergan, Inc. Substituted gamma lactams as therapeutic agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Moustafa, M. A. et al. J. Pharm. Belg. 1987, vol. 42, pages 38-43. *

Also Published As

Publication number Publication date
WO2008024765A2 (en) 2008-02-28
WO2008024765A3 (en) 2008-04-24
US20080058387A1 (en) 2008-03-06
US20100093809A1 (en) 2010-04-15
JP5474548B2 (ja) 2014-04-16
EP2054409A2 (en) 2009-05-06
JP2010501588A (ja) 2010-01-21
AU2007286756A1 (en) 2008-02-28
CA2661827A1 (en) 2008-02-28
US8003678B2 (en) 2011-08-23
JP2014098020A (ja) 2014-05-29
US7659295B2 (en) 2010-02-09
BRPI0715974A2 (pt) 2014-09-16
WO2008024765B1 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
AU2007286177B2 (en) Therapeutic lactams
AU2007272683B2 (en) Substituted cyclopentane derivatives as therapeutic agents
AU2007249443B2 (en) Isothiazolidines useful in the treatment of ocular hypertensive conditions
AU2007286756B2 (en) Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
US7795287B2 (en) Therapeutic substituted hydantoins and related compounds
AU2007267620B2 (en) Therapeutic pyrrolidine compounds
AU2007286135B2 (en) N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives as prostaglandine receptor inhibitors
AU2008216499B2 (en) Gamma-lactams for the treatment of glaucoma or elevated intraocular pressure
US20080033023A1 (en) Therapeutic compounds
US20080027108A1 (en) Therapeutic substituted lactams
US20150274658A1 (en) Therapeutic lactams

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired